Global Depression Drugs Market 2017 Industry Research Report

Table of Contents

1 Depression Drugs Market Overview 1
1.1 Product Overview and Scope of Depression Drugs 1
1.2 Depression Drugs Segment by Types 2
1.2.1 Global Production Market Share of Depression Drugs by Types in 2016 2
1.2.2 SSRIs 3
1.2.3 SNRIs 4
1.3 Depression Drugs Segment by Applications 5
1.3.1 Depression Drugs Consumption Market Share by Applications in 2016 5
1.3.2 Hospitals 6
1.3.3 Clinics 7
1.4 Global Depression Drugs Market by Regions (2012-2022) 8
1.4.1 Global Depression Drugs Market Comparison by Regions 8
1.4.2 North America Depression Drugs Status and Prospect (2012-2022) 9
1.4.3 Asia-Pacific Depression Drugs Status and Prospect (2012-2022) 10
1.4.4 Europe Depression Drugs Status and Prospect (2012-2022) 11
1.4.5 South America Depression Drugs Status and Prospect (2012-2022) 12
1.4.6 Middle East and Africa Depression Drugs Status and Prospect (2012-2022) 13
1.5 Global Depression Drugs Market Size (2012-2022) 14
2 Global Depression Drugs Market Competition by Manufacturers/Brand 15
2.1 Global Depression Drugs Revenue (M USD) and Share by Manufacturers (2015 and 2016) 15
2.2 Global Depression Drugs Gross Margin by Manufacturers (2015 and 2016) 18
2.3 Manufacturers Depression Drugs Headquarters and Established Date 20
2.4 Depression Drugs Market Competitive Situation and Trends 22
2.4.1 Depression Drugs Market Share (%) of Top 3 and Top 5 Manufacturers 22
2.4.2 Mergers & Acquisitions, Expansion 23
3 Global Depression Drugs Sales Revenue (M USD) by Regions (2012-2017) 27
3.1 Global Depression Drugs Revenue (M USD) and Market Share (%) by Regions (2012-2017) 27
3.2 Global Depression Drugs Revenue (M USD) and Gross Margin (%) (2012-2017) 29
3.3 North America Depression Drugs Revenue (M USD) and Gross Margin (%) (2012-2017) 30
3.4 Europe Depression Drugs Revenue (M USD) and Gross Margin (%) (2012-2017) 30
3.5 Asia-Pacific Depression Drugs Revenue (M USD) and Gross Margin (%) (2012-2017) 30
3.6 South America Depression Drugs Revenue (M USD) and Gross Margin (2012-2017) 31
3.7 Middle East and Africa Depression Drugs Revenue (M USD) and Gross Margin (%) (2012-2017) 31
4 Global Depression Drugs Sales Revenue by Types 32
4.1 Global Depression Drugs Revenue and Market Share (%) by Types (2012-2017) 32
4.2 Global Depression Drugs Sales Growth by Type (2012-2017) 34
5 Global Depression Drugs Market Analysis by Applications 35
5.1 Global Depression Drugs Revenue and Market Share (%) by Applications (2012-2017) 35
5.2 Global Depression Drugs Sales Growth Rate (%) by Applications (2012-2017) 37
6 Analysis of Depression Drugs Industry Key Manufacturers 38
6.1 Intellipharmaceutics 38
6.1.1 Company Profile 38
6.1.2 Product Information 39
6.1.3 Revenue, Cost, Gross, and Gross Margin 39
6.2 Pfizer 40
6.2.1 Company Profile 40
6.2.2 Product Information 41
6.2.3 Revenue, Cost, Gross, and Gross Margin 41
6.3 Eli Lilly 41
6.3.1 Company Profile 41
6.3.2 Product Information 42
6.3.3 Revenue, Cost, Gross, and Gross Margin 42
6.4 Astrazeneca 43
6.4.1 Company Profile 43
6.4.2 Product Information 44
6.4.3 Revenue, Cost, Gross, and Gross Margin 44
6.5 Lundbeck 44
6.5.1 Company Profile 44
6.5.2 Product Information 45
6.5.3 Revenue, Cost, Gross, and Gross Margin 46
6.6 Allergan 46
6.6.1 Company Profile 46
6.6.2 Product Information 47
6.6.3 Revenue, Cost, Gross, and Gross Margin 47
6.7 GSK 48
6.7.1 Company Profile 48
6.7.2 Product Information 49
6.7.3 Revenue, Cost, Gross, and Gross Margin 49
6.8 Otsuka Pharmaceutical 49
6.8.1 Company Profile 49
6.8.2 Product Information 50
6.8.3 Revenue, Cost, Gross, and Gross Margin 50
6.9 Takeda 51
6.9.1 Company Profile 51
6.9.2 Product Information 52
6.9.3 Revenue, Cost, Gross, and Gross Margin 52
6.10 NHU Group 53
6.10.1 Company Profile 53
6.10.2 Product Information 54
6.10.3 Revenue, Cost, Gross, and Gross Margin 54
6.11 Shionogi 55
6.11.1 Company Profile 55
6.11.2 Product Information 56
6.11.3 Revenue, Cost, Gross, and Gross Margin 56
6.12 APOTEX 57
6.12.1 Company Profile 57
6.12.2 Product Information 58
6.12.3 Revenue, Cost, Gross, and Gross Margin 58
6.13 Kanghong Pharma 59
6.13.1 Company Profile 59
6.13.2 Product Information 60
6.13.3 Revenue, Cost, Gross, and Gross Margin 61
6.14 HUAHAI 61
6.14.1 Company Profile 61
6.14.2 Product Information 63
6.14.3 Revenue, Cost, Gross, and Gross Margin 63
7 Depression Drugs Manufacturing Cost Analysis 64
7.1 Depression Drugs Key Raw Materials Analysis 64
7.1.1 Key Raw Materials 64
7.1.2 Key Suppliers of Raw Materials 65
7.2 Proportion of Manufacturing Cost Structure 67
7.2.1 Raw Materials 67
7.2.2 Labor Cost 67
7.2.3 Other Costs Analysis 74
7.3 Manufacturing Process Analysis of Depression Drugs 79
8 Industrial Chain, Sourcing Strategy and Downstream Buyers 80
8.1 Depression Drugs Industrial Chain Analysis 80
8.2 Upstream Raw Materials Sourcing 80
8.3 Downstream Buyers 81
9 Marketing Strategy Analysis, Distributors/Traders 84
9.1 Marketing Channel 84
9.1.1 Direct Marketing 84
9.1.2 Indirect Marketing 84
9.1.3 Marketing Channel Development Trend 84
9.2 Market Positioning 85
9.2.1 Pricing Strategy 85
9.2.2 Brand Strategy 86
9.2.3 Target Client 87
9.3 Distributors/Traders List 88
10 Market Effect Factors Analysis 90
10.1 Technology Progress/Risk 90
10.1.1 Substitutes Threat 90
10.1.2 Technology Progress in Related Industry 90
10.2 Consumer Needs/Customer Preference Change 92
10.3 Economic/Political Environmental Change 92
11 Global Depression Drugs Market Forecast (2017-2022) 98
11.1 Global Depression Drugs Revenue (M USD) Forecast (2017-2022) 98
11.2 Global Depression Drugs Revenue (M USD) Forecast by Regions (2017-2022) 98
11.2.1 North America Depression Drugs Revenue (M USD) Forecast (2017-2022) 101
11.2.2 Europe Depression Drugs Revenue (M USD) Forecast (2017-2022) 102
11.2.3 Asia-Pacific Depression Drugs Revenue (M USD) Forecast (2017-2022) 103
11.2.4 South America Depression Drugs Revenue (M USD) Forecast (2017-2022) 104
11.2.5 Middle East and Africa Depression Drugs Revenue (M USD) Forecast (2017-2022) 105
11.3 Global Depression Drugs Revenue by Type (2017-2022) 105
11.4 Global Depression Drugs Revenue Forecast by Application (2017-2022) 106
12 Research Findings and Conclusion 108
13 Appendix 109
Author List 109
Disclosure Section 110
Research Methodology 110
Data Source 111
China Disclaimer 111



List of Tables and Figures

Figure Picture of Depression Drugs 1
Table Classification of Depression Drugs 2
Figure Global Production Market Share of Depression Drugs by Types in 2016 3
Figure Product Picture of SSRIs 3
Figure Product Picture of SNRIs 4
Table Applications of Depression Drugs 5
Figure Depression Drugs Consumption Market Share by Applications in 2016 6
Figure Hospitals 6
Figure Clinics 7
Figure Global Depression Drugs Market Share by Regions 2016 8
Figure North America Depression Drugs Revenue (M USD) and Growth Rate (%) (2012-2022) 9
Figure Asia-Pacific Depression Drugs Revenue (M USD) and Growth Rate (%) (2012-2022) 10
Figure Europe Depression Drugs Revenue (M USD) and Growth Rate (%) (2012-2022) 11
Figure South America Depression Drugs Revenue (M USD) and Growth Rate (%) (2012-2022) 12
Figure Middle East and Africa Depression Drugs Revenue (M USD) and Growth Rate (%) (2012-2022) 13
Figure Global Depression Drugs Revenue (M USD) Status and Outlook (2012-2022) 14
Table Global Depression Drugs Revenue (M USD) by Manufacturers (2015 and 2016) 15
Table Global Depression Drugs Revenue Share (%) by Manufacturers (2015 and 2016) 15
Figure 2015 Global Depression Drugs Revenue Share (%) by Manufacturers 17
Figure 2016 Global Depression Drugs Revenue Share (%) by Manufacturers 18
Table Global Market Depression Drugs Gross Margin of Key Manufacturers (2015 and 2016) 18
Figure Global Market Depression Drugs Gross Margin of Key Manufacturers in 2016 20
Table Manufacturers Depression Drugs Headquarters and Established Date 20
Table Manufacturers Depression Drugs Brand and Sales Area 21
Figure Depression Drugs Market Share (%) of Top 3 Manufacturers 2016 22
Figure Depression Drugs Market Share (%) of Top 5 Manufacturers 2016 23
Table Mergers & Acquisitions, Expansion 23
Table Global Depression Drugs Revenue (M USD) by Regions (2012-2017) 27
Table Global Depression Drugs Revenue Market Share (%) by Regions (2012-2017) 27
Figure Global Depression Drugs Revenue Market Share (%) by Regions (2012-2017) 28
Figure 2012 Global Depression Drugs Revenue Market Share (%) by Regions 28
Figure 2016 Global Depression Drugs Revenue Market Share (%) by Regions 29
Table Global Depression Drugs Revenue (M USD) and Gross Margin (%) (2012-2017) 29
Table North America Depression Drugs Revenue (M USD) and Gross Margin (%) (2012-2017) 30
Table Europe Depression Drugs Revenue (M USD) and Gross Margin (%) (2012-2017) 30
Table Asia-Pacific Depression Drugs Revenue (M USD) and Gross Margin (%) (2012-2017) 30
Table South America Depression Drugs Revenue (M USD) and Gross Margin (%) (2012-2017) 31
Table Middle East and Africa Depression Drugs Revenue (M USD) and Gross Margin (%) (2012-2017) 31
Table Global Depression Drugs Revenue (M USD) by Types (2012-2017) 32
Table Global Depression Drugs Revenue Share (%) by Types (2012-2017) 32
Figure Revenue Share (%) of Depression Drugs by Types (2012-2017) 33
Figure 2016 Revenue Market Share (%) of Depression Drugs by Types 33
Figure Global Depression Drugs Sales Growth (%) by Type (2012-2017) 34
Table Global Depression Drugs Revenue by Applications (2012-2017) 35
Table Global Depression Drugs Revenue Market Share (%) by Applications (2012-2017) 35
Figure Global Depression Drugs Revenue Market Share (%) by Applications (2012-2017) 36
Figure Global Depression Drugs Revenue Market Share (%) by Applications in 2016 36
Table Global Depression Drugs Sales Growth Rate (%) by Applications (2012-2017) 37
Figure Global Depression Drugs Sales Growth Rate (%) by Applications (2012-2017) 37
Table Intellipharmaceutics Company Profile 38
Figure Depression Drugs Product Picture of Intellipharmaceutics 39
Table Depression Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Intellipharmaceutics 2015-2016 39
Table Pfizer Company Profile 40
Figure Depression Drugs Product Picture of Pfizer 41
Table Depression Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Pfizer 2015-2016 41
Table Eli Lilly Company Profile 41
Figure Depression Drugs Product Picture of Eli Lilly 42
Table Depression Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Eli Lilly 2015-2016 42
Table Astrazeneca Company Profile 43
Figure Depression Drugs Product Picture of Astrazeneca 44
Table Depression Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Astrazeneca 2015-2016 44
Table Lundbeck Company Profile 44
Figure Depression Drugs Product Picture of Lundbeck 45
Table Depression Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Lundbeck 2015-2016 46
Table Allergan Company Profile 46
Figure Depression Drugs Product Picture of Allergan 47
Table Depression Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Allergan 2015-2016 47
Table GSK Company Profile 48
Figure Depression Drugs Product Picture of GSK 49
Table Depression Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of GSK 2015-2016 49
Table Otsuka Pharmaceutical Company Profile 49
Figure Depression Drugs Product Picture of Otsuka Pharmaceutical 50
Table Depression Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Otsuka Pharmaceutical 2015-2016 50
Table Takeda Company Profile 51
Figure Depression Drugs Product Picture of Takeda 52
Table Depression Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Takeda 2015-2016 52
Table NHU Group Company Profile 53
Figure Depression Drugs Product Picture of NHU Group 54
Table Depression Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of NHU Group 2015-2016 54
Table Shionogi Company Profile 55
Figure Depression Drugs Product Picture of Shionogi 56
Table Depression Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Shionogi 2015-2016 56
Table APOTEX Company Profile 57
Figure Depression Drugs Product Picture of APOTEX 58
Table Depression Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of APOTEX 2015-2016 58
Table Kanghong Pharma Company Profile 59
Figure Depression Drugs Product Picture of Kanghong Pharma 60
Table Depression Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Kanghong Pharma 2015-2016 61
Table HUAHAI Company Profile 61
Figure Depression Drugs Product Picture of HUAHAI 63
Table Depression Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of HUAHAI 2015-2016 63
Table Raw Material Suppliers Analysis and Picture 64
Table Key Suppliers of Raw Materials 65
Table Manufacturing Cost Structure of Depression Drugs 67
Figure USA Overview of Average Hourly Wages 2016-2017 (USD/Hour) 68
Figure USA Overview of Labor Costs 2013-2016 (110 Index Points) 68
Figure Cost of Employing a Factory Worker 70
Figure 2016 Estimated Labor Costs for the Whole Economy in Europe 71
Figure Monthly Minimum Wages in Asia 2016 72
Figure China Overview of Average Yearly Wages 2016-2017 (CNY/Year) 73
Figure Japan Overview of Average Monthly Wages 2016-2017 (JPY Thousand/Month) 73
Table Average Price of Electricity to Ultimate Customers 74
Figure Electricity Prices for Household Consumers in 2016 75
Figure Summary of the Driving Assumptions 76
Figure Industrial Electric Rates 2016 (PER KWH) 77
Figure Manufacturing Process Analysis of Depression Drugs 79
Figure Depression Drugs Industrial Chain Analysis 80
Table Major Buyers of Depression Drugs 81
Figure Setting Pricing Policy 85
Table Distributors/Traders List 88
Figure Global GDP Map 2016 93
Figure EU GDP Change 2006-2016 93
Figure German CPI Change 2016-2017 94
Figure UK CPI Change 2007-2016 94
Figure Japan GDP Change 2014-2017 95
Figure Japan CPI Change in 2016 95
Figure China GDP Change 2014-2017 95
Figure China CPI Change 2016-2017 96
Figure US GDP Change 2013-2016 96
Figure US CPI Change 2016-2017 97
Figure Global Depression Drugs Revenue (M USD) and Growth Rate (%) Forecast (2017-2022) 98
Table Global Depression Drugs Revenue Forecast by Regions (2017-2022) 98
Table Global Depression Drugs Sales Market Share (%) Forecast by Regions (2017-2022) 99
Figure Global Depression Drugs Sales Market Share (%) Forecast by Regions (2017-2022) 99
Figure Global Depression Drugs Sales Market Share (%) Forecast by Regions 2022 100
Figure North America Depression Drugs Revenue and Growth Rate (%) Forecast (2017-2022) 101
Figure Europe Depression Drugs Revenue and Growth Rate (%) Forecast (2017-2022) 102
Figure Asia-Pacific Depression Drugs Revenue and Growth Rate (%) Forecast (2017-2022) 103
Figure South America Depression Drugs Revenue and Growth Rate (%) Forecast (2017-2022) 104
Figure Middle East and Africa Depression Drugs Revenue and Growth Rate (%) Forecast (2017-2022) 105
Table Global Depression Drugs Revenue (M USD) Forecast by Type (2017-2022) 105
Table Global Depression Drugs Revenue Market Share (%) Forecast by Type (2017-2022) 105
Figure Global Depression Drugs Revenue Market Share (%) Forecast by Type (2017-2022) 106
Table Global Depression Drugs Revenue Forecast by Application (2017-2022) 106
Figure Global Depression Drugs Sales Forecast by Application (2017-2022) 107

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.

Menu 3

Eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo.